288d

From Proteopedia

(Difference between revisions)
Jump to: navigation, search
Line 4: Line 4:
|PDB= 288d |SIZE=350|CAPTION= <scene name='initialview01'>288d</scene>, resolution 1.800&Aring;
|PDB= 288d |SIZE=350|CAPTION= <scene name='initialview01'>288d</scene>, resolution 1.800&Aring;
|SITE=
|SITE=
-
|LIGAND= <scene name='pdbligand=DM8:2'-BROMO-4'-EPIDAUNORUBICIN'>DM8</scene>
+
|LIGAND= <scene name='pdbligand=DM8:2&#39;-BROMO-4&#39;-EPIDAUNORUBICIN'>DM8</scene>
|ACTIVITY=
|ACTIVITY=
|GENE=
|GENE=
Line 29: Line 29:
[[Category: right handed dna]]
[[Category: right handed dna]]
-
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Thu Mar 20 15:43:39 2008''
+
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Sun Mar 23 14:33:39 2008''

Revision as of 12:33, 23 March 2008


PDB ID 288d

Drag the structure with the mouse to rotate
, resolution 1.800Å
Ligands:
Coordinates: save as pdb, mmCIF, xml



SUBSTITUTIONS AT C2' OF DAUNOSAMINE IN THE ANTICANCER DAUNORUBICIN ALTER ITS DNA-BINDING SEQUENCE SPECIFICITY


Overview

In the search for new generations of anthracycline drugs, lower cytotoxic side effect and higher activity toward resistant cancer cells are two major goals. A new anthracycline drug, WP401 (2'-bromo-4'-epidaunorubicin, alpha-manno configuration), exhibits promising activity toward multidrug-resistant cells. In contrast, the related compound WP400 (2'-bromo-4'-epidaunorubicin, alpha-gluco configuration), is significantly less cytotoxic. To establish the structural and molecular bases of this observation, we performed X-ray diffraction analyses of the complexes between WP401 and four DNA hexamers CGTACG, CGATCG, CGCGCG, and CGGCCG. Their crystal data (space group P4(1)2(1)2, a = b approximately 2.8 nm, c approximately 5.3 nm) are similar to those of other daunorubicin/doxorubicin complexes. The refined crystal structures at 0.18-nm resolution revealed that two WP401 drug molecules bind to the duplex, with the aglycons intercalated between the CpG steps and their modified daunosamines in the minor groove. The bulky bromine atom at the C2' position caused the daunosamine of the bound WP401 to adopt a different conformation from that of the bound daunorubicin. In the presence of formaldehyde, WP401 formed a covalent adduct with CGGCCG more readily than with CGCGCG. This is the opposite of what is seen for daunorubicin and doxorubicin. Thus modifications at the C2' position of daunosamine modulate the sequence specificity of the formaldehyde-crosslinking reactions between anthracyclines and DNA.

About this Structure

288D is a Protein complex structure of sequences from [1]. Full crystallographic information is available from OCA.

Reference

Substitutions at C2' of daunosamine in the anticancer drug daunorubicin alter its DNA-binding sequence specificity., Gao YG, Priebe W, Wang AH, Eur J Biochem. 1996 Sep 1;240(2):331-5. PMID:8841395

Page seeded by OCA on Sun Mar 23 14:33:39 2008

Proteopedia Page Contributors and Editors (what is this?)

OCA

Personal tools